Kaplan Gilla

DirectorTyra Biosciences, Inc. (TYRA) · full profile →Form 4 · filed Jun 16, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$535K
Net Open-Market Flow
-$535K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 16, 2025Sell(S)7K$10.38$71K38K
Jun 13, 2025Sell(S)15K$10.31$155K45K
Jun 12, 2025Sell(S)30K$10.31$309K60K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-086960) within minutes of acceptance. Every field above traces to the original document. Verify it directly: